Gabather
0.18
SEK
+23.29 %
GABA
First North Stockholm
Biotechnology & Pharmaceuticals
Health Care
Less than 1K followers
+23.29%
-55%
-55%
-68.75%
-74.72%
-83.01%
-95.94%
-97.01%
-98.87%
Gabather is a pharmaceutical company. Today, there is a business focus on developing drug candidates for the treatment of nerve diseases. Particular focus is on the stimulation of gamma-aminobutyric acid, which is the main inhibitory neurotransmitter in the brain. The drug candidates are today patented on a global level. Gabather was established in 2014 and is headquartered in Malmö.
Read moreMarket cap
4.27M SEK
Turnover
47.9K SEK
Revenue
-
EBIT %
-
P/E
-
Dividend yield-%
-
Financial calendar
21/2
2025
Annual report '24
21/2
2025
Extraordinary general meeting '25
28/5
2025
Interim report Q1'25
ShowingAll content types
Gabather AB: KALLELSE TILL EXTRA BOLAGSSTÄMMA I GABATHER AB (publ)
Gabather AB: Styrelsen för Gabather beslutar om en företrädesemission av units om högst cirka 23,5 MSEK och upptar brygglån om 0,75 MSEK
Join Inderes community
Don't miss out - create an account and get all the possible benefits
Inderes account
Followings and notifications on followed companies
Analyst comments and recommendations
Stock comparison tool & other popular tools